about
Perioperative treatment options in resectable pancreatic cancer - how to improve long-term survivalTreatment of gastric outlet obstruction that results from unresectable gastric cancer: Current evidenceContactin 1: A potential therapeutic target and biomarker in gastric cancerPositioning of second-line treatment for advanced gastric and gastroesophageal junction adenocarcinomaSunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program.Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancerNon-platinum-based chemotherapy for treatment of advanced gastric cancer: 5-fluorouracil, taxanes, and irinotecan.The relationship of vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer.Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapySinomenine sensitizes gastric cancer cells to 5-fluorouracil in vitro and in vivoTreatment Patterns, Costs, and Survival among Medicare-Enrolled Elderly Patients Diagnosed with Advanced Stage Gastric Cancer: Analysis of a Linked Population-Based Cancer Registry and Administrative Claims Database.Gene therapy with SOCS1 for gastric cancer induces G2/M arrest and has an antitumour effect on peritoneal carcinomatosis.Nicotine Inhibits Cisplatin-Induced Apoptosis via Regulating α5-nAChR/AKT Signaling in Human Gastric Cancer CellsPreoperative Body Mass Index, Blood Albumin and Triglycerides Predict Survival for Patients with Gastric Cancer.Modified glasgow prognostic score as a prognostic factor in gastriccancer patients: a systematic review and meta-analysisFirst-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status.Shikonin induces mitochondria-mediated apoptosis and enhances chemotherapeutic sensitivity of gastric cancer through reactive oxygen species.Signal transducer and activator of transcription 3 signaling upregulates fascin via nuclear factor-κB in gastric cancer: Implications in cell invasion and migration.Isolated ovarian metastasis of gastric cancer: Krukenberg tumor.Differences in symptom occurrence, severity, and distress ratings between patients with gastrointestinal cancers who received chemotherapy alone or chemotherapy with targeted therapy.Synergistic antitumor effects of combined deguelin and cisplatin treatment in gastric cancer cellsDownregulation of Inhibition of Apoptosis-Stimulating Protein of p53 (iASPP) Suppresses Cisplatin-Resistant Gastric Carcinoma In Vitro.The HER4-YAP1 axis promotes trastuzumab resistance in HER2-positive gastric cancer by inducing epithelial and mesenchymal transition.Apoptin-derived peptide reverses cisplatin resistance in gastric cancer through the PI3K-AKT signaling pathway.
P2860
Q26753854-994C1A0B-9D06-4F0E-BE7E-EBB6F0F61055Q26767109-E0571E08-98A0-4FF7-B723-76366493DE7EQ26781524-488F8A3E-9A9C-4F76-8F28-C84C3FA7FFA1Q28079750-4E5CA3E9-BE03-45B7-836E-5C909A4B9837Q30313895-5212F3FC-B0FA-4DB9-90A6-DF0D59F2E3C7Q33589802-2690AB8E-B937-4B14-B8AD-163FF8237A32Q33594906-9585F177-49B8-429B-85D8-E88579349745Q34572068-02E221A4-D078-4FE2-823F-FF19C40A630BQ34857119-CDF166E8-6ABB-4504-9A6B-CF164F790324Q35048000-37CD414A-26DB-4C02-9272-EDC460A28499Q35833346-6A264291-54D5-4C34-ACC3-E8542F0A8FB8Q35909650-79577F2C-2A85-4D71-8C36-CB750EE0B94CQ35933632-1D2B0B19-6D5C-4234-9C93-A2B3F4070212Q36053971-F652B111-9AF8-4C7F-A923-14FD75BC928BQ36317466-2E3BB202-016B-4D1F-B4C6-A40F0D79FA8AQ36409085-AC484366-B49C-4A47-8193-121ECE3E2EF3Q37459939-4FA00A87-FD82-4D19-ADA7-07F5A6C011EFQ37574906-DC8D8C56-5B50-46C2-81AA-35E54695E226Q37601885-0666B83B-5648-47BA-B27F-833E916B8C78Q37677564-FBBA1BE6-B1E1-440C-9DF4-0C2EBD3EC105Q38958264-D942AD0E-8142-4312-946C-C1DDB6CF0F9FQ47097970-EB5BA6F9-6DCB-42C9-8D76-20BE0C44A07FQ52657273-A2385B4E-74AB-48E8-B7F5-870045318EC5Q52664553-0353B019-A9F9-4A98-8DD4-0E9249ABD02D
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The role of chemotherapy in metastatic gastric cancer.
@ast
The role of chemotherapy in metastatic gastric cancer.
@en
The role of chemotherapy in metastatic gastric cancer.
@nl
type
label
The role of chemotherapy in metastatic gastric cancer.
@ast
The role of chemotherapy in metastatic gastric cancer.
@en
The role of chemotherapy in metastatic gastric cancer.
@nl
prefLabel
The role of chemotherapy in metastatic gastric cancer.
@ast
The role of chemotherapy in metastatic gastric cancer.
@en
The role of chemotherapy in metastatic gastric cancer.
@nl
P2093
P1433
P1476
The role of chemotherapy in metastatic gastric cancer
@en
P2093
Anna Paola Fraccon
Felice Pasini
Giovanni DE Manzoni
P304
P407
P577
2011-10-01T00:00:00Z